PMU-98009-30976
4 vaccinations
1 coded response
42 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 857 / AZ
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
- 2021-04-16
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-16
-
2021-11-02
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2022-02-01
- 2022-05-03
-
2022-10-08
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-02
- 2022-11-05
- 2022-11-12
- 2022-11-19
-
2023-01-07
Survey response — 3 months, dose 4MedDRA: Anosmia, Chills, Cough, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | Flu |
| 4 | 2022-10-08 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release